The screening test revealed that the patient is heterozygous for the ARMS2 (G/T), IL-8 (C/T) and wild-type for CFH (T/T) polymorphisms, meaning that the patient is approximately 5 times more likely to develop AMD during his lifetime. This evidence concerns the gene CXCL8 and age-related macular degeneration.